Skip to main content

MedWellAI, Inc.

corporate_fare Company Profile

MedWellAI, Inc.

MWAI·OTC·Crypto Assets·CIK 0001520118

MedWellAI, Inc. operates a fully automated e-commerce platform that facilitates the sale of GLP-1 weight management therapies, peptides, and other compounds. The company earns commissions by connecting in-office buyers with multiple FDA-registered 503B pharmacies. MedWellAI, Inc. was incorporated in Nevada on March 22, 2011, initially as Lightcollar, Inc., and changed its name to MedWellAI, Inc. in June 2025. Its headquarters are in Clearwater, Florida. The company also provides a turnkey, custom solution for qualified procurement agents and resellers. This solution allows them to market in-office use products to licensed healthcare providers, wellness spas, and telemedicine companies. The platform is designed to be 100% automated, cost-effective, efficient, compliant, and profitable, requiring no infrastructure investment from the users. Key features of the platform include access to multiple 503B outsourcing facilities, over 100 products, personalized pricing, direct payment deposits, custom domain options, and onboarding support. The platform manages seamless ordering, fulfillment, and shipping directly through the 503B facilities. In July 2024, MedWellAI, Inc. formed three wholly-owned subsidiaries in Nevada: MedWell Direct, LLC, MedWell Facilities, LLC, and MedWell USA, LLC. On August 29, 2024, through MedWell Direct, the company acquired 51% of the membership interests of Healthy Lifestyle USA LLC, a Florida limited liability company.

MedWellAI, Inc. (OTC:MWAI) is a publicly traded company in the Crypto Assets sector. Wiseek has independently scored 6 items for MWAI at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-16, rated 8/10. Across its 6 most recent items scored 7 or higher, the top rating is 9/10, with 5 rated 8 or above. Recent SEC coverage for MWAI spans 10-Q, 10-K, 5, 8-K.

Recent high-impact activity:

  • MedWellAI Q1 Loss Narrows to $287K, Yet Going Concern and Default Linger
  • MedWellAI 10-K: Going Concern, $7.85M Working Capital Deficit, and Material Weaknesses
  • CEO Steve Rubakh Discloses $281K Stock Purchase, Now Owns ~50.8% of MedWellAI
  • MedWellAI Reports Worsening $7.6M Working Capital Deficit and New $6.5M Convertible Preferred Stock Liability Amid Strategic Shift
  • MedWellAI Increases Authorized Series B Convertible Preferred Stock by 50%

Financial Snapshot

Fiscal year ended June 30, 2026
Revenue
$527.86K
Net Income
-$1.59M
Op. Cash Flow
-$307.03K
Free Cash Flow
-$307.03K
Operating Income
-$1.24M
Cash & Equivalents
$86.22K
Debt / Equity
0.00×
Net Margin
-301.1%
Shares Outstanding
6.54M sh
Source: 10-K · filed 2026-10-13 · accession 0001477932-26-006180

Short Interest & Short Volume

1.00 days to cover

FINRA reported short interest of 2,855 shares in MWAI as of the October 30, 2026 settlement, a 11.7% increase from the prior period — about 1.0 days to cover at its recent average daily volume. On November 18, 2026, 50.0% of MWAI volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)2,855 shares as of October 30, 2026
Change vs prior period▲ 11.7%
Days to cover1.00 at avg daily volume of 8,490
Daily short volume (FINRA facilities)50.0% of 118 shares on November 18, 2026

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with M →
$0.297 +3.13% today
52-week range · as of 2026-11-16 $0.157 – $0.8007
Market cap
$1.94M
Volume
415 (0.1× avg)
3-mo avg 3.1K
Live data · 2026-11-21 06:00 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed MWAI - Latest Insights

MWAI
Nov 16, 2026, 4:30 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.297
Real-time Price: $0.297 info
Change: $0 (0%) info
Market Cap: $1.941M info
MWAI
Oct 13, 2026, 2:47 PM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $0.370
Real-time Price: $0.297 info
Change: -$0.073 (-20%) info
Market Cap: $1.941M info
MWAI
Jun 18, 2026, 6:50 AM EDT
Filing Type: 5
Importance Score:
9
Price at Filing: $0.2586
Real-time Price: $0.297 info
Change: +$0.0384 (+15%) info
Market Cap: $1.941M info
MWAI
May 05, 2026, 4:06 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.387
Real-time Price: $0.297 info
Change: -$0.090 (-23%) info
Market Cap: $1.941M info
MWAI
Apr 17, 2026, 4:04 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.370
Real-time Price: $0.297 info
Change: -$0.073 (-20%) info
Market Cap: $1.941M info
MWAI
Feb 23, 2026, 2:39 PM EST
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.429
Real-time Price: $0.297 info
Change: -$0.132 (-31%) info
Market Cap: $1.941M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets